Commonwealth Equity Services’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Commonwealth Equity Services’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,760	Closed	-$205K	–	2866
2018 Q3	$205K	Buy	3,760 +115	+3%	+$7.86K	﹤0.01%	2487
2018 Q2	$302K	Buy	3,645 +30	+0.8%	+$2.31K	﹤0.01%	2121
2018 Q1	$240K	Buy	+3,615	New	+$209K	﹤0.01%	2253
2017 Q4	–	Sell	-2,884	Closed	-$257K	–	2745
2017 Q3	$257K	Buy	+2,884	New	+$219K	﹤0.01%	2090

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Commonwealth Equity Services's ONCE Position: Q4 2018 in Review

Commonwealth Equity Services sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2018, closing a stake of 3,760 shares — an estimated $205K sold.

Commonwealth Equity Services first reported a position in ONCE in Q3 2017 and held it in 4 quarters. The position peaked at $302K in Q2 2018. 157 funds tracked by Wall St. Rank hold ONCE as of Q4 2018.

Commonwealth Equity Services reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Commonwealth Equity Services sold 3,760 Spark Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $205K.
Commonwealth Equity Services first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
Commonwealth Equity Services's Spark Therapeutics, Inc. Common Stock position peaked at $302K in Q2 2018.
157 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Commonwealth Equity Services's 13F filing for Q4 2018, filed 11 Feb 2019.